Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study

Fertility and Sterility

Volumn 90, Issue 4, 2008, Pages 1087-1093

  Schachter, Morey ^a   Friedler, Shevach ^a   Ron El, Raphael ^a   Zimmerman, Ariel L ^a   Strassburger, Deborah ^a   Bern, Orna ^a   Raziel, Arieh ^a  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

endometrium; GnRH agonist; GnRH antagonist; GnRH receptor; implantation

Indexed keywords

CHORIONIC GONADOTROPIN; DIPHERELINE; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PROGESTERONE; TRIPTORELIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG BINDING; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR ASPIRATION; FOLLITROPIN BLOOD LEVEL; HUMAN; HUMAN CELL; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; PREGNANCY RATE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

ADULT; DRUG THERAPY, COMBINATION; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; INCIDENCE; INFERTILITY, FEMALE; OOCYTE RETRIEVAL; PREGNANCY; PREGNANCY RATE; PREMEDICATION; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 52949134515     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.07.1316     Document Type: Article

References (21)

1. Beckers T., Bernd M., Kutscher B., Kuhne R., Hoffmmans S., and Reissman T. Structure-function studies of linear and cyclized peptide antagonists of the GnRH receptor. Biochem Biophys Res Commun 289 (2001) 653-663
2. Itskovitz-Eldor J., Kol S., and Mannaerts B. Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of OHSS: preliminary report. Hum Reprod 15 (2000) 1965-1968
3. Egbase P.E., Grudzinskas J.G., Al Sharhan M., and Ashkenani L. HCG or GnRH agonist to trigger ovulation in GnRH antagonist-treated intrauterine insemination cycles: a prospective randomized study. Abstracts of the 18th meeting of the ESHRE (2002), Information Press, Ltd., Oxford, UK 2
4. Beckers N.G., Macklon N.S., Eijkemans M.J., Ludwig M., Felderbaum R., Diedrich K., et al. Nonsupplemented luteal phase characteristics after the administration of recombinant HCG, recombinant LH, or GnRH agonist to induce final oocyte maturation in IVF patients after ovarian stimulation with recombinant FSH and GnRH antagonist cotreatment. J Clin Endocrinol Metab 88 (2003) 4186-4192
5. Al-Inany H., Abou-Setta A.M., and Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception. Cochrane Database Syst Rev 3 (2006) CD001750
6. Albano C., Felderbaum R.E., Smitz J., Riethemuller-Winzen H., Engel J., Diedrich K., et al. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the LHRH antagonist cetrorelix and the LHRH agonist buserelin. Hum Reprod 15 (2000) 526-531
7. Zikopoulos K., Kolibianakis E.M., Camus M., Tournaye H., Van den Abbeel E., Joris H., et al. Duration of GnRH antagonist administration does not effect the outcome of subsequent frozen-thawed cycles. Fertil Steril 81 (2004) 473-475
8. Kol S., Lightman A., Hilljensjo T., Devroey P., Fauser B., and Tarlazis B. High doses of GnRH antagonist in IVF cycles do not adversely affect the outcome of subsequent freeze-thaw cycles. Hum Reprod 14 (1999) 2242-2244
9. Hernandez E. Embryo implantation and GnRH antagonists: embryo implantation: the Rubicon for GnRH antagonists. Hum Reprod 15 (2000) 1211-1216
10. Raga F., Casan E.M., Kruessel J.S., Wen Y., Huang H.Y., Nezhat C., et al. Quantitative GnRH gene expression and immunohistochemical localization in human endometrium throughout the menstrual cycle. Biol Reprod 59 (1998) 661-669
11. Luo X., Xu J., and Chegini N. GnRH analogue alters the expression and activation of Smad in human endometrial epithelial and stromal cells. Reprod Biol Endocrinol 16 (2003) 125
12. Meresman G.F., Bilotas M.A., Lombardi E., Tesone M., Sueldo C., and Baranao R.I. Effect of GnRH analogues on apoptosis and release of IL-1 beta and VEGF in endometrial cell cultures from patients with endometriosis. Hum Reprod 18 (2003) 1767-1771
13. Tesarik J., Hazout A., and Mendoza C. Enhancement of embryo developmental potential by a single administration of GnRH agonist at the time of implantation. Hum Reprod 19 (2004) 1175-1180
14. Tesarik J., Hazout A., Mendoza-Tesarik R., Mendoza N., and Mendoza C. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles. Hum Reprod 21 (2006) 2572-2579
15. Pirard C., Donnez J., and Loumaye E. GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study. Hum Reprod 21 (2006) 1894-1900
16. Kolibianakis E.M., Collins J., Tarlatzis B.C., Devroey P., Diedrich K., and Griesinger A. Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update 12 (2006) 651-671
17. Devroey P., Bourgain C., Macklon N.S., and Fauser B.C.J.M. Reproductive biology and IVF: ovarian stimulation and endometrial receptivity. Trends Endocrinol Metabol 15 (2004) 84-90
18. Fauser B.C.J.M., de Jong D., Olivennes F., Wramsby H., Tay C., Itskovitch-Eldor J., et al. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for IVF. J Clin Endocrinol Metab 87 (2002) 709-715
19. Humaidan P., Ejdrup Bredkjaer H., Bungum L., Bungum M., Grondahl M.L., Westergaard L., et al. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Hum Reprod 20 (2005) 1213-1220
20. Kolibianakis E.M., Schultze-Mosgau A., Schroer A., Van Steirteghem A., Devroey P., Diedrich K., et al. A lower ongoing pregnancy rate can be expected when GnRH agonist is used to trigger final oocyte maturation instead of hCG in patients undergoing IVF with GnRH antagonists. Hum Reprod 20 (2005) 2887-2892
21. Raga F., Casan E.M., Kruessel J., Wen Y., Bonilla-Musoles F., and Polan M.L. The role of gonadotropin-releasing hormone in murine preimplantation embryonic development. Endocrinology 140 (1999) 3705-3712